Laddar...
Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges
Diabetic retinopathy (more specifically diabetic macular edema, DME) is the most common cause of loss of vision in the working population in developed countries. Anti-vascular endothelial growth factor (anti-VEGF) agents considerably changed the treatment algorithms and improved prognosis of center-...
Sparad:
| I publikationen: | Adv Ther |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Healthcare
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5487872/ https://ncbi.nlm.nih.gov/pubmed/28484955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0548-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|